VETOQUINOL Aktie
| 76,00EUR | -2,90EUR | -3,68% |
WKN DE: A0LEWB / ISIN: FR0004186856
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 2 546 | 2 521 | 2 483 | 2 501 | 2 486 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,20 | 0,21 | 0,21 | 0,22 | 0,21 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 274 | 309 | 363 | 421 | 0 |
| Summe Anlagevermögen | 351 | 343 | 329 | 323 | 0 |
| Summe Aktiva | 625 | 652 | 692 | 744 | 0 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 183 | 167 | 165 | 168 | 0 |
| Summe Eigenkapital | 441 | 485 | 527 | 576 | 0 |
| Summe Passiva | 625 | 652 | 692 | 744 | 0 |
Adresse
| 34, rue du Chêne Sainte-Anne, 70200 Lure | |
| Telefon | +33 (3) 84-62-55-55 |
| Fax | +33 (3) 84-62-55-56 |
| Internet | http://www.vetoquinol.com |
Management
|
Alain Masson
Deputy CEO & Pharmacist Manager |
|
Anne-Marie Graffin
Independent Director |
|
Audrey Chanoinat
Director |
|
Dominique Derveaux
Chief Operating Officer |
|
Fanny Toillon
Investor Relations Contact |
|
Jean-Yves Ravinet
Deputy Chief Executive Officer |
|
Laurent Thoré
Director-Legal Affairs |
|
Louis Champel
Independent Director |
|
Luc Frechin
Director |
|
Marie-Josèphe Baud
Independent Director |
|
Matthieu Jean Frechin
Chairman & Chief Executive Officer |
|
Michael Donabédian
Group Director-Research & Intellectual Property |
|
Nathalie Arlecchini
Group Director-Human Resources |
|
Philippe Arnold
Independent Director |
|
Philippe Gruet
Chief Scientific Officer |
|
Régis Vimal du Monteil
Chief Financial Officer |
|
Sandrine Perrier
Chief Information Officer |
|
Stephane Villemin
Group Director-Marketing & Medical |
|
Étienne Frechin
Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.